akhatri

/akhatri

About akhatri

This author has not yet filled in any details.
So far akhatri has created 132 blog entries.

Reminder: Endorsing invoice prices correctly

Community Pharmacy England would like to remind pharmacy teams of the correct prescription endorsement requirements for invoice prices and pack size information required for certain items. An endorsement of an invoice price and pack size is required on prescriptions for: Products not listed in Part VIIIA of the Drug Tariff where the endorsed product (brand, [...]

The post Reminder: Endorsing invoice prices correctly appeared first on Community Pharmacy England.

By |November 17th, 2026|Lexpos News|Comments Off on Reminder: Endorsing invoice prices correctly

MHRA Class 4 Medicines Defect Notification: Enalapril maleate/ Hydrochlorothiazide 20 mg/12.5 mg Tablets (Star Pharmaceuticals Ltd)

MHRA Class 4 Medicines Defect Notification: Enalapril maleate/ Hydrochlorothiazide 20 mg/12.5 mg Tablets (Star Pharmaceuticals Ltd) Drug alert number: EL(26)A/48 Date issued: 12 November 2026 Star Pharmaceuticals Limited have informed the MHRA of a typographical error on the strength of hydrochlorothiazide printed on the front face of the carton which incorrectly states “12. mg” instead of [...]

The post MHRA Class 4 Medicines Defect Notification: Enalapril maleate/ Hydrochlorothiazide 20 mg/12.5 mg Tablets (Star Pharmaceuticals Ltd) appeared first on Community Pharmacy England.

By |November 12th, 2026|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Enalapril maleate/ Hydrochlorothiazide 20 mg/12.5 mg Tablets (Star Pharmaceuticals Ltd)

Expiry of SSP087 Ramipril 1.25mg capsules

The Department of Health and Social Care (DHSC) has confirmed the Serious Shortage Protocol (SSP087) for Ramipril 1.25mg capsules will expire at 23:59pm Friday 30th October 2026. After this date, any prescriptions for Ramipril 1.25mg capsules must be dispensed in accordance with the prescription. Top tips for SSP claims Where available, use the claim amend [...]

The post Expiry of SSP087 Ramipril 1.25mg capsules appeared first on Community Pharmacy England.

By |October 30th, 2026|Lexpos News|Comments Off on Expiry of SSP087 Ramipril 1.25mg capsules

MHRA Class 2 Medicines Recall: Mynzepli 40 mg/mL solution for injection in pre-filled syringe (Advanz Pharma Limited)

MHRA Class 2 Medicines Recall: Mynzepli 40 mg/mL solution for injection in pre-filled syringe (Advanz Pharma Limited). Drug alert number: EL(26)A/44 Date issued: 29 October 2026 Advanz Pharma Limited are recalling specified batches of Mynzepli 40 mg/mL solution for injection in pre-filled syringe as a precautionary measure. DMRC reference number: DMRC-41252013 Company name: Advanz Pharma Limited [...]

The post MHRA Class 2 Medicines Recall: Mynzepli 40 mg/mL solution for injection in pre-filled syringe (Advanz Pharma Limited) appeared first on Community Pharmacy England.

By |October 29th, 2026|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Mynzepli 40 mg/mL solution for injection in pre-filled syringe (Advanz Pharma Limited)

MHRA Drug Safety Update: #MedSafetyWeek (2 to 8 November 2026)

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that the annual #MedSafetyWeek campaign is taking place from 2 to 8 November 2026 to promote the importance of reporting side effects from medicines and medical device incidents. This year’s theme is ‘Side effects: don’t ignore them, report them!’ The Yellow Card scheme relies on [...]

The post MHRA Drug Safety Update: #MedSafetyWeek (2 to 8 November 2026) appeared first on Community Pharmacy England.

By |October 28th, 2026|Lexpos News|Comments Off on MHRA Drug Safety Update: #MedSafetyWeek (2 to 8 November 2026)